Brian Baranick - 27 Feb 2023 Form 4 Insider Report for EXACT SCIENCES CORP (EXAS)

Role
Gen. Mgr., Precision Oncology
Signature
/s/ Brian Baranick by Mark R. Busch, attorney-in-fact
Issuer symbol
EXAS
Transactions as of
27 Feb 2023
Net transactions value
-$118,084
Form type
4
Filing time
01 Mar 2023, 16:16:26 UTC
Previous filing
28 Feb 2023
Next filing
08 Aug 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EXAS Common Stock Options Exercise $0 +3,954 +72% $0.000000 9,441 27 Feb 2023 Direct F1
transaction EXAS Common Stock Sale $118,084 -1,932 -20% $61.12 7,509 28 Feb 2023 Direct F2, F3
holding EXAS Common Stock 159 27 Feb 2023 Held in 401(k) Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EXAS Restricted Stock Units Options Exercise $0 -3,954 -25% $0.000000 11,863 27 Feb 2023 Common Stock 3,954 Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock received upon vesting of a restricted stock unit award.
F2 Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain restricted stock units on February 27, 2023.
F3 In addition to the shares of Common Stock reported on this Form 4, which total 7,668 shares, Mr. Baranick also holds, in the aggregate, an additional 39,644 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.
F4 Each restricted stock unit represents a contingent right to receive one share of common stock.
F5 Represents a restricted stock unit award that partially vested on February 27, 2023. The restricted stock units vest in four equal annual installments beginning on February 25, 2023.